Al-Kali, Aref

Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia

Stahl, Maximilian , DeVeaux, Michelle, Montesinos, Pau , Itzykson, Raphaël , Ritchie, Ellen K. , Sekeres, Mikkael A. , Brunner, Andrew M. , Komrokji, Rami S. , Bhatt, Vijaya Raj , Al‐Kali, Aref , Cluzeau, Thomas , Santini, Valeria , Fenaux, Pierre , Litzow, Mark R. , Fathi, Amir T. , Kim, Tae Kon , Vey, Norbert , Germing, Ulrich , Bergua, Juan , Gore, Steven D. , Zeidan, Amer M. , Al-Kali, Aref , Litzow, Mark R. , Prebet, Thomas , Komrokji, Rami S , Bergua, Juan Miguel , Sekeres, Mikkael A , Montesinos, Pau , Bhatt, Vijaya Raj , Itzykson, Raphael , Santini, Valeria , Kim, Tae Kon , Barnard, John , Podoltsev, Nikolai , Roboz, Gail J. , Perreault, Sarah , Prébet, Thomas , Verma, Vivek , Serrano, Josefina , Zeidan, Amer M

Leukemia & Lymphoma | July 2, 2018 | Volume: 60 | Issue: 1 | Pages: 246-249

10.1080/10428194.2018.1468893